Please Wait.....
Report
North America Tumor Ablation Market Report and Forecast 2024-2032
Market Report I 2024-06-26 I 120 Pages I EMR Inc.
North America Tumor Ablation Market Report and Forecast 2024-2032
North America Tumor Ablation Market Outlook
The North America tumor ablation market size was valued at USD 0.71 billion in 2023, driven by the rising prevalence and incidence of cancer in the region. The market is expected to grow at a CAGR of 12.30% during the forecast period of 2024-2032, with the values likely to rise from USD 0.79 billion in 2024 to USD 2.01 billion by 2032.
Key Takeaways
- In March 2024 , Medtronic plc announced FDA 501 (k) clearance for its bone tumor ablation system called OsteoCool 2.0 to treat benign bone tumors and painful bone metastases.
- The American Cancer Society estimated around 2,001,140 new cancer cases and 611,720 deaths caused by cancer in the United States in 2024.
- In September 2023 , the United States Food and Drug Administration (FDA) approved ablation treatment planning and confirmation software, VisAble.IO, to facilitate image-guided ablation therapy.
North America Tumor Ablation Market Analysis
Tumor ablation is a minimally invasive technique in which interventional radiologists guide a needle-tipped catheter directly into a tumor, followed by applying extreme heat or cold to destroy or shrink the tumor. Imaging techniques are generally used to precisely find the tumor location. The ability of tumor ablation treatment to shrink tumors can increase the longevity of patients, relieve pain, and even in some cases, cure cancer. The technical success of the treatment and its minimally invasive nature is expected to drive the North America tumor ablation market demand in the coming years.
Cancer ranks as the second leading cause of mortality in the United States. American Cancer Society estimated around 2,001,140 new cancer cases and 611,720 deaths are projected to affect the United States population in 2024. The rising cancer burden directly impacts the demand for effective treatment approaches to tackle the mortality rate caused by the disease. Thus, the growing prevalence of cancer is expected to positively influence the North America tumor ablation market share in the region.
The market is witnessing a surge in approvals from health regulatory authorities such as the United States Food and Drug Administration (FDA). In March 2024 , United States based Medtronic plc announced FDA 501 (k) clearance for its bone tumor ablation system called OsteoCool 2.0. The upgraded design of the radiofrequency ablation system allows efficient treatment of benign bone tumors and painful bone metastases. The device can use four internally cooled probes at the same time and delivers 20W per channel, with the company claiming it as the most powerful bone tumor ablation on the market. Further, the company plans to introduce the product in the United States market this year. The launch of such innovative ablation systems is likely to augment the North America tumor ablation market growth in the forecast period.
The market is witnessing technological innovation in the field of tumor ablation systems which are increasing treatment precision and improving patient outcomes. In September 2023 , the United States Food and Drug Administration (FDA) granted approval to ablation treatment planning and confirmation software, VisAble.IO, developed by Techsomed, an Israeli-based medical device company. The software uses the company's artificial intelligence-driven technology called BioTrace and facilitates image-guided ablation therapy, offering various advantages such as three-dimensional visualization of the ablation target. The rising integration of artificial intelligence in tumor ablation treatment is expected to optimize patient care and fuel market growth.
Other factors that drive the market share include the rising investment from the public and private sectors, heightened public awareness regarding the benefits of the technique, and the expanding applications of tumor ablation systems.
North America Tumor Ablation Market Segmentation??
"North America Tumor Ablation Market Report and Forecast 2024-2032" offers a detailed analysis of the market based on the following segments:
Market Breakup by Technology
- Radiofrequency (RF)Ablation
- Microwave Ablation
- Cryoablation
- Irreversible Electroporation
- Others
Market Breakup by Mode of Treatment
- Surgical Ablation
- Laparoscopic Ablation
- Percutaneous Ablation
- Others
Market Breakup by Application
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Bone Metastasis
- Others
Market Breakup by End User
- Hospital and Clinics
- Specialty Centers
- Others
Market Breakup by Countries
- United States of America
- Canada
North America Tumor Ablation Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Sonacare Medical
- Medtronic Plc
- EDAP TMS
- Angiodynamics
- Healthtronics, INC
- Johnson & Johnson
- Boston Scientific Corporation
- Misonix, INC
- Biotronik
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
FAQs
- What was the North America tumor ablation market value in 2023?
The market attained a value of about USD 0.71 billion in 2023 driven by the rising prevalence and incidence of cancer in the region.
- What is the North America tumor ablation market forecast outlook for 2024-2032?
The market is anticipated to grow at a CAGR of 12.30% during the forecast period of 2024-2032, likely to reach a market value of USD 2.01 billion by 2032.
- What are the major factors aiding the North America tumor ablation market demand?
Technological innovations in tumor ablation systems and the rising preference for minimally invasive techniques are fuelling the demand for the market.
- What are the major North America tumor ablation market trends?
One of the significant trends in the market is the surge in approvals from health regulatory authorities such as the United States FDA. In March 2024 , Medtronic plc announced 501 (k) clearance for its bone tumor ablation system called OsteoCool 2.0. The upgraded design of the radiofrequency ablation system allows efficient treatment of benign bone tumors and painful bone metastases.
- What is the market segmentation based on technology?
Based on the technology, the market is segmented into radiofrequency (RF) ablation, microwave ablation, cryoablation, and irreversible electroporation, among others.
- What is the market breakup by mode of treatment?
By mode of treatment, the market is divided into surgical ablation, laparoscopic ablation, and percutaneous ablation, among others.
- What are the major end users of tumor ablation market in North America?
End users of the market are hospitals, clinics, and specialty centers, among others.
- What are the applications of North America tumor ablation market?
Major application areas of tumor ablation include liver cancer, lung cancer, kidney cancer, and bone metastasis, among others.
- What is the market segmentation by countries?
The market segmentation by countries includes the United States of America and Canada.
- Who are the key players involved in the North America tumor ablation market?
The key players in the market are Sonacare Medical, Medtronic Plc, EDAP TMS, Angiodynamics, Healthtronics, INC, Johnson & Johnson, Boston Scientific Corporation, Misonix, INC, and Biotronik.
Meta description
The North America tumor ablation market size was valued at USD 0.71 billion in 2023 and it is anticipated to grow at a CAGR of 12.30% during the forecast period of 2024-2032.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 North America Tumor Ablation Market Overview
3.1 North America Tumor Ablation Market Historical Value (2017-2023)
3.2 North America Tumor Ablation Market Forecast Value (2024-2032)
4 North America Tumor Ablation Market Landscape*
4.1 North America Tumor Ablation: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 North America Tumor Ablation: Product Landscape
4.2.1 Analysis by Technology
4.2.2 Analysis by Mode of Treatment
5 North America Tumor Ablation Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter's Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 North America Tumor Ablation Market Segmentation (2017-2032)
6.1 North America Tumor Ablation Market (2017-2032) by Technology
6.1.1 Market Overview
6.1.2 Radiofrequency (RF) Ablation
6.1.3 Microwave Ablation
6.1.4 Cryoablation
6.1.5 Irreversible Electroporation
6.1.6 Others
6.2 North America Tumor Ablation Market (2017-2032) by Mode of Treatment
6.2.1 Market Overview
6.2.2 Surgical Ablation
6.2.3 Laparoscopic Ablation
6.2.4 Percutaneous Ablation
6.2.5 Others
6.3 North America Tumor Ablation Market (2017-2032) by Application
6.3.1 Market Overview
6.3.2 Liver Cancer
6.3.3 Lung Cancer
6.3.4 Kidney Cancer
6.3.5 Bone Metastasis
6.3.6 Others
6.4 North America Tumor Ablation Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Hospital and Clinics
6.4.3 Specialty Centers
6.4.4 Others
6.5 North America Tumor Ablation Market (2017-2032) by Countries
6.5.1 Market Overview
6.5.2 United States of America
6.5.3 Canada
7 United States of America Tumor Ablation Market (2017-2032)
7.1 United States of America Tumor Ablation Market (2017-2032) by Technology
7.1.1 Market Overview
7.1.2 Radiofrequency (RF)Ablation
7.1.3 Microwave Ablation
7.1.4 Cryoablation
7.1.5 Irreversible Electroporation
7.1.6 Others
7.2 United States of America Tumor Ablation Market (2017-2032) by Mode of Treatment
7.2.1 Market Overview
7.2.2 Surgical Ablation
7.2.3 Laparoscopic Ablation
7.2.4 Percutaneous Ablation
7.2.5 Others
7.3 United States of America Tumor Ablation Market (2017-2032) by Application
7.3.1 Market Overview
7.3.2 Liver Cancer
7.3.3 Lung Cancer
7.3.4 Kidney Cancer
7.3.5 Bone Metastasis
7.3.6 Others
7.4 United States of America Tumor Ablation Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Hospital and Clinics
7.4.3 Specialty Centers
7.4.4 Others
8 Canada Tumor Ablation Market (2017-2032)
8.1 Canada Tumor Ablation Market (2017-2032) by Technology
8.1.1 Market Overview
8.1.2 Radiofrequency (RF)Ablation
8.1.3 Microwave Ablation
8.1.4 Cryoablation
8.1.5 Irreversible Electroporation
8.1.6 Others
8.2 Canada Tumor Ablation Market (2017-2032) by Mode of Treatment
8.2.1 Market Overview
8.2.2 Surgical Ablation
8.2.3 Laparoscopic Ablation
8.2.4 Percutaneous Ablation
8.2.5 Others
8.3 Canada Tumor Ablation Market (2017-2032) by Application
8.3.1 Market Overview
8.3.2 Liver Cancer
8.3.3 Lung Cancer
8.3.4 Kidney Cancer
8.3.5 Bone Metastasis
8.3.6 Others
8.4 Canada Tumor Ablation Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Hospital and Clinics
8.4.3 Specialty Centers
8.4.4 Others
9 Regulatory Framework
10 Patent Analysis
10.1 Analysis by Type of Patent
10.2 Analysis by Publication year
10.3 Analysis by Issuing Authority
10.4 Analysis by Patent Age
10.5 Analysis by CPC Analysis
10.6 Analysis by Patent Valuation
10.7 Analysis by Key Players
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 Sonacare Medical
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 Medtronic Plc
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 EDAP TMS
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Angiodynamics
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 Healthtronics, Inc.
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Johnson & Johnson
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 Boston Scientific Corporation
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 Misonix, INC
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 Biotronik
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic Reach and Achievements
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
14 North America Tumor Ablation Market - Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security